Open AccessThis article is
- freely available
Recent Evidence Regarding Triclosan and Cancer Risk
Department of Public Health, University of Tennessee, Knoxville, TN 37996, USA
Department of Surgery, University of Tennessee Medical Center, Knoxville, TN 37920, USA
* Author to whom correspondence should be addressed.
Received: 16 January 2014; in revised form: 12 February 2014 / Accepted: 13 February 2014 / Published: 21 February 2014
Abstract: Triclosan is a broad-spectrum antibacterial commonly used in cosmetics, dentifrices, and other consumer products. The compound’s widespread use in consumer products and its detection in breast milk, urine, and serum have raised concerns regarding its potential association with various human health outcomes. Recent evidence suggests that triclosan may play a role in cancer development, perhaps through its estrogenicity or ability to inhibit fatty acid synthesis. Our aims here are to review studies of human exposure levels, to evaluate the results of studies examining the effects of triclosan on cancer development, and to suggest possible directions for future research.
Keywords: triclosan; epidemiologic studies; breast neoplasms; cancer; xenoestrogens; fatty acid synthesis
Citations to this Article
Cite This Article
MDPI and ACS Style
Dinwiddie, M.T.; Terry, P.D.; Chen, J. Recent Evidence Regarding Triclosan and Cancer Risk. Int. J. Environ. Res. Public Health 2014, 11, 2209-2217.
Dinwiddie MT, Terry PD, Chen J. Recent Evidence Regarding Triclosan and Cancer Risk. International Journal of Environmental Research and Public Health. 2014; 11(2):2209-2217.
Dinwiddie, Michael T.; Terry, Paul D.; Chen, Jiangang. 2014. "Recent Evidence Regarding Triclosan and Cancer Risk." Int. J. Environ. Res. Public Health 11, no. 2: 2209-2217.